Evaxion A/SEVAX

NasdaqHealthcareBiological Products, (No Diagnostic Substances)
Price (close)
$3.26
Market cap
$29.4M
P/E
—
Revenue (FY)
$7.5M
Net income
-$7.7M
Dividend yield
—
1-year total return
-28.0%
Net margin
-102.4%
Revenue growth
125.1%
Debt / equity
0.31x

What Evaxion A/S does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue——$0$73,000$3.3M$7.5M
Net income-$15.0M-$24.5M-$23.2M-$22.1M-$10.6M-$7.7M
Free cash flow-$12.6M-$23.2M-$26.1M-$17.8M-$12.9M-$6.6M

More on EVAX.

Figures from Evaxion A/S's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.